Company: PBH
Filing Date: 2025-05-09
Form Type: 10-K
Source: 0001295947-25-000017
Chunk: 74

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-05-09
Form: 10-K
Item: Item 7
Chunk 74
---
2,518)(2.0)Oral Care81,868 7.2 83,212 7.4 (1,344)(1.6)Other OTC12,582 1.1 11,644 1.0 938 8.1 Total North American OTC Healthcare960,010 84.4 958,260 85.2 1,750 0.2 International OTC HealthcareAnalgesics5,524 0.5 5,455 0.5 69 1.3 Cough & Cold23,681 2.1 25,445 2.3 (1,764)(6.9)Women's Health20,496 1.8 23,318 2.1 (2,822)(12.1)Gastrointestinal81,052 7.1 70,721 6.2 10,331 14.6 Eye & Ear Care24,464 2.2 22,870 2.0 1,594 7.0 Dermatologicals8,177 0.7 5,814 0.5 2,363 40.6 Oral Care13,162 1.2 13,093 1.2 69 0.5 Other OTC1,196 —381 —815 213.9 Total International OTC Healthcare177,752 15.6 167,097 14.8 10,655 6.4 Total Consolidated$1,137,762 100.0 $1,125,357 100.0 $12,405 1.1 

Total segment revenues for 2025 were $1,137.8 million, an increase of $12.4 million, or 1.1%, versus 2024.

North American OTC Healthcare Segment

Revenues for the North American OTC Healthcare segment increased $1.8 million, or 0.2%, during 2025 versus 2024.  The $1.8 million increase was primarily attributable to an increase in sales in the Gastrointestinal category, partly offset by a decrease in sales in the Cough & Cold category.  

International OTC Healthcare Segment

Revenues for the International OTC Healthcare segment increased $10.7 million, or 6.4%, during 202